Celltrion Pharm Creates a New Future
Jungjin Seo Honorary Chairman, Celltrion Group
Our beginning was humble.
We started with a dream.
A dream to benefit patients with affordable drugs.
While the other Korean pharmaceutical companies focused on the domestic market, we looked out into the world.
We saw an opportunity in the biosimilar market.
By investing almost half of our earnings to R&D, we succeeded in gaining approval in the strict biosimilar space.
We created and led the world’s first “antibody biosimilar market,” a market that even the world’s multinational pharmaceutical giants could not dream of starting.
Now, Celltrion ventures toward the world,
to become a global leader and lead the future of Korea’s biopharmaceutical industry.
We are here thanks to the efforts of many.
We will remember all those who helped us get where we are today, and continue our efforts to contribute to society, the world, and humankind through our business.